Role of cannabis in cardiovascular disorders
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The growing popularity of medical and recreational consumption of cannabis, especially among the youth, raises immediate concerns regarding its safety and long-terms effects. The cardiovascular effects of cannabis are not well known. Cannabis consumption has been shown to cause arrhythmia including ventricular tachycardia, and potentially sudden death, and to increase the risk of myocardial infarction (MI). These effects appear to be compounded by cigarette smoking and precipitated by excessive physical activity, especially during the first few hours of consumption. Cannabinoids, or the active compounds of cannabis, have been shown to have heterogeneous effects on central and peripheral circulation. Acute cannabis consumption has been shown to cause an increase in blood pressure, specifically systolic blood pressure (SBP), and orthostatic hypotension. Cannabis use has been reported to increase risk of ischemic stroke, particularly in the healthy young patients. The endocannabinoid system (ECS) is currently considered as a promising therapeutic target in the management of several disease conditions. Synthetic cannabinoids (SCs) are being increasingly investigated for their therapeutic effects; however, the value of their benefits over possible complications remains controversial. Despite the considerable research in this field, the benefits of cannabis and its synthetic derivatives remains questionable even in the face of an increasingly tolerating attitude towards recreational consumption and promotion of the therapeutic complications. More efforts are needed to increase awareness among the public, especially youth, about the cardiovascular risks associated with cannabis use and to disseminate the accumulated knowledge regarding its ill effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Cited by
The association of cannabis use and cardiac dysrhythmias: a systematic review
Richards, J. R., Blohm, E., Toles, K. A., Jarman, A. F., Ely, D. F., & Elder, J. W. (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1743847 · Cited by 82
“Both CB receptor subtypes are also located in the myocardium and vascular endothelium [71,72].”
BackgroundPatel, R. S., Kamil, S. H., Bachu, R., Adikey, A., Ravat, V., Kaur, M., Tankersley, W. E., & Goyal, H. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.003 · Cited by 67
Self-citationYeung, M. E. M., Weaver, C. G., Janz, K., Haines-Saah, R., & Lang, E. (2020) · CJEM · doi:10.1017/cem.2020.384 · Cited by 56
Genome-wide DNA methylation analysis of heavy cannabis exposure in a New Zealand longitudinal cohort
Osborne, A. J., Pearson, J. F., Noble, A. J., Gemmell, N. J., Horwood, L. J., Boden, J. M., Benton, M. C., Macartney-Coxson, D. P., & Kennedy, M. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0800-3 · Cited by 47
Cannabis in liver disorders: a friend or a foe?
Goyal, H., Rahman, M. R., Perisetti, A., Shah, N., & Chhabra, R. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001256 · Cited by 33
Self-citation
Metadata
- Authors
- Goyal, H., Awad, H. H., & Ghali, J. K.
- Venue
- Journal of Thoracic Disease
- Publisher
- AME Publishing Company
- Published
- 2017-07
- Volume
- 9
- Issue
- 7
- Pages
- 2079-2092
- ISSN
- 2072-1439 (ISSN-L)
- 2077-6624
- OpenAlex
- W2734678203
- Cited by
- 224
- References
- 2
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.